Avonex

Interferon Beta-1A

8.5 High risk

Avonex & Multiple sclerosis relapse

5.5%

of users reported Multiple sclerosis relapse

83.5%

also reported Hospitalization

77.7%

are women

Most common medical consequences

Hospitalization
83.5%
Severe reaction
15.6%
Disability
0.5%
Death
0.3%
Birth Defects
<0.1%
Life-threatening condition
<0.1%

Have you experienced any negative side effects from this medication?

Avonex: general information

Most common side effects (1157)

Most commonly affected ages

0 - 9 years
0.3%
10 - 19 years
1.3%
20 - 29 years
4.6%
30 - 39 years
12.0%
40 - 49 years
18.0%
50 - 59 years
27.6%
60 - 69 years
24.2%
70 - 79 years
10.8%
80 - 89 years
1.1%
On this page
Avonex & Multiple sclerosis relapse
Avonex: general information